14th March
TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations
28th July
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations You can read the full article below....
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
TriviumVet Sponsor renowned ECVPT European College of Veterinary Pharmacology & Toxicology Event
10th July
It was a busy week last week in TriviumVet as we were delighted to be a sponsor of the European College of Veterinary Pharmacology and Toxicology Cardiorenal Symposium. Our CRA...
After selling two pharma firms, Louise Grubb is preparing for the US launch of a treatment for heart disease in cats
7th July
Check out this July 2023 feature in one of Irelands national papers - The Independent Can you always tell when an animal is in pain? Not always, says Louise Grubb,...
Spotlight Series - The CHASE Questionnaire to Assess the Safety and Efficacy of a Novel Pain Management Product in Dogs
25th May
Spotlight on CHASE This Spotlight Series focuses on The CHASE Study - a multicenter clinical trial using the Chiari-like Malformation & Syringomyelia Evaluation (CHASE)...
Cutting edge Feline Hypertrophic Cardiomyopathy Research to be presented to the American College of Veterinary Internal Medicine (ACVIM)
20th April
Two exciting pieces of feline hypertrophic cardiomyopathy (HCM) research are to be presented to the American College of Veterinary Internal Medicine (ACVIM) this year on their...
TriviumVet CEO Louise Grubb wins IMAGE PwC Business Woman of the Year 2023 Award
17th April
Serial entrepreneur Louise Grubb, founder and CEO of the game-changing companion animal diagnosis and treatment business TriviumVet, was awarded the overall title of Businesswoman...
TriviumVet appoint healthcare powerhouse Helen Ryan as Chairperson of their board
17th February
TriviumVet™ are delighted to announce that Helen Ryan has been appointed as our new board Chairperson. CEO Louise Grubb comments of the appointment “Having a Chairperson of...
Understanding Feline HCM: Prognosis, Genetic Mutations and Emerging Treatment Options Dr. Joshua Stern, UC Davis
3rd February
Dr. Joshua Sterns presentation from VMX 2023
Spotlight Series - The "REVERSE" Feline Chronic Kidney Disease Study at The Ohio State University Veterinary School
17th November
Spotlight on REVERSE The first post in our Spotlight Series where we shine a light on one of our Clinical Trials or Projects. One of our most exciting projects at TriviumVet is...
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
TriviumVet Sponsor renowned ECVPT European College of Veterinary Pharmacology & Toxicology Event
10th July
It was a busy week last week in TriviumVet as we were delighted to be a sponsor of the European College of Veterinary Pharmacology and Toxicology Cardiorenal Symposium. Our CRA...
After selling two pharma firms, Louise Grubb is preparing for the US launch of a treatment for heart disease in cats
7th July
Check out this July 2023 feature in one of Irelands national papers - The Independent Can you always tell when an animal is in pain? Not always, says Louise Grubb,...
Spotlight Series - The CHASE Questionnaire to Assess the Safety and Efficacy of a Novel Pain Management Product in Dogs
25th May
Spotlight on CHASE This Spotlight Series focuses on The CHASE Study - a multicenter clinical trial using the Chiari-like Malformation & Syringomyelia Evaluation (CHASE)...
Cutting edge Feline Hypertrophic Cardiomyopathy Research to be presented to the American College of Veterinary Internal Medicine (ACVIM)
20th April
Two exciting pieces of feline hypertrophic cardiomyopathy (HCM) research are to be presented to the American College of Veterinary Internal Medicine (ACVIM) this year on their...
TriviumVet CEO Louise Grubb wins IMAGE PwC Business Woman of the Year 2023 Award
17th April
Serial entrepreneur Louise Grubb, founder and CEO of the game-changing companion animal diagnosis and treatment business TriviumVet, was awarded the overall title of Businesswoman...
TriviumVet appoint healthcare powerhouse Helen Ryan as Chairperson of their board
17th February
TriviumVet™ are delighted to announce that Helen Ryan has been appointed as our new board Chairperson. CEO Louise Grubb comments of the appointment “Having a Chairperson of...
Understanding Feline HCM: Prognosis, Genetic Mutations and Emerging Treatment Options Dr. Joshua Stern, UC Davis
3rd February
Dr. Joshua Sterns presentation from VMX 2023
Spotlight Series - The "REVERSE" Feline Chronic Kidney Disease Study at The Ohio State University Veterinary School
17th November
Spotlight on REVERSE The first post in our Spotlight Series where we shine a light on one of our Clinical Trials or Projects. One of our most exciting projects at TriviumVet is...